DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Consensus Rating of “Hold” by Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) has received a consensus rating of “Hold” from the twelve analysts that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and three have given a buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $48.11.

Several brokerages have recently commented on XRAY. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Monday, August 15th. Piper Sandler dropped their target price on shares of DENTSPLY SIRONA from $41.00 to $38.00 in a research report on Monday, July 11th. William Blair cut shares of DENTSPLY SIRONA from a “market perform” rating to an “underperform” rating in a research report on Friday, August 5th. The Goldman Sachs Group dropped their target price on shares of DENTSPLY SIRONA from $42.00 to $41.00 and set a “neutral” rating for the company in a research report on Thursday, July 21st. Finally, Morgan Stanley decreased their price target on shares of DENTSPLY SIRONA from $48.00 to $44.00 and set an “overweight” rating on the stock in a report on Wednesday, July 20th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of XRAY. Nuance Investments LLC lifted its position in shares of DENTSPLY SIRONA by 356.3% during the 2nd quarter. Nuance Investments LLC now owns 9,051,338 shares of the medical instruments supplier’s stock valued at $323,404,000 after acquiring an additional 7,067,751 shares during the period. BlackRock Inc. raised its holdings in DENTSPLY SIRONA by 36.1% during the first quarter. BlackRock Inc. now owns 24,083,158 shares of the medical instruments supplier’s stock worth $1,185,372,000 after buying an additional 6,382,605 shares during the last quarter. Wellington Management Group LLP raised its holdings in DENTSPLY SIRONA by 83.1% during the first quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock worth $270,829,000 after buying an additional 2,497,773 shares during the last quarter. Lazard Asset Management LLC raised its holdings in DENTSPLY SIRONA by 11,805,127.3% during the second quarter. Lazard Asset Management LLC now owns 1,298,575 shares of the medical instruments supplier’s stock worth $46,397,000 after buying an additional 1,298,564 shares during the last quarter. Finally, American Century Companies Inc. raised its holdings in DENTSPLY SIRONA by 8,220.9% during the first quarter. American Century Companies Inc. now owns 1,292,987 shares of the medical instruments supplier’s stock worth $63,641,000 after buying an additional 1,277,448 shares during the last quarter. Institutional investors and hedge funds own 96.00% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of DENTSPLY SIRONA stock opened at $28.41 on Friday. The company has a 50-day simple moving average of $33.10 and a two-hundred day simple moving average of $37.71. The stock has a market capitalization of $6.12 billion, a price-to-earnings ratio of 16.81, a price-to-earnings-growth ratio of 2.45 and a beta of 0.94. The company has a quick ratio of 1.03, a current ratio of 1.45 and a debt-to-equity ratio of 0.38. DENTSPLY SIRONA has a twelve month low of $28.12 and a twelve month high of $59.46.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be issued a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a yield of 1.76%. The ex-dividend date is Thursday, September 29th. DENTSPLY SIRONA’s payout ratio is 29.59%.

DENTSPLY SIRONA Company Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Further Reading

Analyst Recommendations for DENTSPLY SIRONA (NASDAQ:XRAY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider DENTSPLY SIRONA, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and DENTSPLY SIRONA wasn’t on the list.

While DENTSPLY SIRONA currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Source

Leave a Reply

Your email address will not be published. Required fields are marked *